Treatment of Femoro-popliteal Atherosclerotic Lesions Using the Ranger Paclitaxel Coated Balloon Catheter. All Comers Registry.

Atherosclerotic Disease Clinical Trial

Official title:
Ranger DEB All Comers Registry - Treatment of Femoro-popliteal Atherosclerotic Lesions Using the Ranger Paclitaxel Coated Balloon Catheter: An All Comers Registry.

Status Completed

Clinical Trial Summary

A total of up to 250 patients from an all-comers patient population with infrainguinal atherosclerotic disease who are implanted or scheduled for an implant with a Ranger Drug coated balloon.

Interim analysis will be carried out for every 50 subjects enrolled.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Atherosclerotic Disease

Clinical Trial Details

NCT number	NCT02462005
Study type	Observational [Patient Registry]
Source	Klinikum Arnsberg
Contact
Status	Completed
Phase
Start date	February 2015
Completion date	May 2019

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT03314818` - Natural History of Carotid Plaque as Determined by 3D Ultrasound	N/A
Recruiting	`NCT03480568` - Alirocumab in Patients on a Stable Dialysis Regimen	Phase 3
Recruiting	`NCT02176941` - Telomeres and Arterial Aging	N/A
Completed	`NCT00673985` - Edwards Lifesciences Self-Expanding Stent Peripheral Vascular Disease Study	N/A
Completed	`NCT00090168` - Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED)	Phase 3
Completed	`NCT00738725` - BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-Risk Population	N/A
Completed	`NCT00352222` - Safety and Efficacy of Express LD to Treat Stenosed or Occlusive Atherosclerotic Disease in Iliac Arteries	Phase 3
Completed	`NCT02546648` - PeriOperative ISchemic Evaluation-3 Trial: A Pilot Study	Phase 3